Drugs / NUV001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06133478 | Nov 2023 → Mar 2024 | — | Nuvamid SA | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NUV001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06133478 ↗ |
| Route | Oral | “NUV001 will be given orally at four dose levels.” NCT06133478 ↗ |